Alambic Investment Management’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
Alambic Investment Management's ANGO Position: Q1 2020 in Review
Alambic Investment Management sold out of AngioDynamics (ANGO) in Q1 2020, closing a stake of 31,706 shares — an estimated $508K sold.
Alambic Investment Management first reported a position in ANGO in Q4 2015 and held it in 14 quarters. The position peaked at $4.03M in Q1 2018. 158 funds tracked by Wall St. Rank hold ANGO as of Q1 2020.
- Alambic Investment Management reported no remaining AngioDynamics position as of Q1 2020 after selling out during the quarter.
- Alambic Investment Management sold 31,706 AngioDynamics shares in Q1 2020, an estimated $508K.
- Alambic Investment Management first reported a position in AngioDynamics in Q4 2015 and held it in 14 quarters.
- Alambic Investment Management's AngioDynamics position peaked at $4.03M in Q1 2018.
- 158 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2020.
Based on Alambic Investment Management's 13F filing for Q1 2020, filed 11 May 2020.